Ontario launches POC (point of care) HIV testing programme
This article was originally published in Clinica
Ontario is launching free point of care (POC) testing for HIV - a move that it claims is a Canadian first. The programme features a 60-second on-site antibody test, said to be "as accurate as current laboratory-based testing in Ontario", though the presence of antibodies will require lab-based confirmation of HIV-positive status. It will also entail a doubling of the number of testing sites.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.